Serum-Soluble Human Leukocyte Antigen-G Serves as a Biomarker for Early Gastric Cancer Screening among the Elderly People
Digestive Diseases · 2025
DOI: 10.1159/000547447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases, 2025. Verfasst von Shuangzhen Bao und 2 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, Hengshui People's Hospital, Hengshui, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Early Detection of Cancer, Biomarkers, Tumor, HLA-G Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Introduction
Gastric cancer is a major cause of gastrointestinal cancer deaths, and early detection is key to improving survival. Current diagnostic methods have limitations, highlighting the need for new biomarkers. Our study aimed to explore the potential of serum-soluble human leukocyte antigen-G (sHLA-G), pepsinogen I/pepsinogen II (PGI/PGII) ratio (PGR), and gastrin-17 (G17) as markers for diagnosing and monitoring gastric cancer progression.
Methods
A retrospective study was conducted to analyze serum levels of sHLA-G, PGR, and G17. These levels were compared among various gastric conditions, including chronic non-atrophic gastritis, chronic atrophic gastritis, precancerous lesions, and gastric cancer. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic performance of these biomarkers.
Results
This study included 429 elderly patients who underwent gastric examination. Results showed that serum levels of sHLA-G and G17 were significantly higher while PGR levels were significantly lower in the gastric cancer group (all p < 0.001). ROC analysis revealed that the combined model of sHLA-G, PGR, and G17 had the best diagnostic performance (AUC = 0.89, sensitivity 86.90%, specificity 76.52%). Additionally, sHLA-G levels were closely associated with cancer progression, tumor size, lymph node metastasis, and Helicobacter pylori infection, suggesting it may serve as a biomarker for gastric cancer progression.
Conclusion
Serum sHLA-G can serve as an effective biomarker for gastric cancer screening, revealing a better effective diagnostic performance in combination with PGR and G-17. The combination of these biomarkers enhances diagnostic accuracy and may facilitate early diagnosis and risk stratification of gastric cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery Department, Hengshui People's Hospital, Hengshui, China.
- Department of Neurology, Hengshui People's Hospital, Hengshui, China.
Zitieren
APA
Bao, S., Wang, X., & Zhao, J. (2025). Serum-Soluble Human Leukocyte Antigen-G Serves as a Biomarker for Early Gastric Cancer Screening among the Elderly People. Digestive Diseases. https://doi.org/10.1159/000547447
Vancouver
Bao S, Wang X, Zhao J. Serum-Soluble Human Leukocyte Antigen-G Serves as a Biomarker for Early Gastric Cancer Screening among the Elderly People. Digestive Diseases. 2025. doi:10.1159/000547447
BibTeX
@article{Bao2025,
author = {Bao, Shuangzhen and Wang, Xinying and Zhao, Jiangang},
title = {Serum-Soluble Human Leukocyte Antigen-G Serves as a Biomarker for Early Gastric Cancer Screening among the Elderly People},
journal = {Digestive Diseases},
year = {2025},
doi = {10.1159/000547447}
}
EUVIMED